(A) Representative immunofluorescence images of cortical brain tissue sections from patients with AD stained with A11 (green) and 6E10 (red). Merge is presented along with a representative co-localization pixel map and intensity scatter plot. (B) IF co-staining with A11 (green) with OC (red). Merge is presented with a representative co-localization pixel map and intensity scatter plot. (C) IF co-staining of A11 (green) with Tau13 (red). Merge is presented with a representative co-localization pixel map and intensity scatter plot (PCC=0.89). (D) IF co-staining with A11 (green) with TDP-43-Oligo01 (red). Merge is presented with a representative co-localization pixel map and intensity scatter plot (PCC=0.87). (E) IF co-staining of A11 (green) with TDP-43-Oligo02 (red). Merge is presented with a representative co-localization pixel map and intensity scatter plot (PCC=0.88). (F) Pearson coefficient scatter plot of combined co-staining of A11 with OC, Tau13, TDP-43-Oligo01, andTDP-43-Oligo02 (from left to right). All images were taken with a 20x objective and represented in green (A11), red (other antibodies) and merge, white scale bar: 100 μm. Representative co-localization (green+red=grey) pixel maps represent random ROIs enlarged, and the scatter plot is related to those 10 ROIs (n=3 for each AD case analyzed).